EDCTP2’s funding of research and capacity development
(2014–2024)
Towards EDCTP’s objectives
(2014–2024)
437 projects awarded to date.
€829.43 M
Total funding
Fellowship programme
Clinical research capacity
Collaborative clinical trials and clinical studies
HIV & HIV-associated infections, 20 grants
€115.55 M
Malaria, 17 grants
€139.20 M
Emerging diseases, 33 grants
€196.83 M
Neglected infectious diseases, 19 grants
€70.60 M
Diarrhoeal diseases, 6 grants
€53.15 M
Lower respiratory tract infections, 8 grants
€41.45 M
Tuberculosis, 33 grants
€196.83 M
By intervention
By disease
Collaborative clinical trials and clinical studies
>2,000
peer-reviewed publications acknowledging the second programme.
5
new/improved medical interventions, including an albendazole–ivermectin combination treatment for parasitic worm infections, arpraziquantel for treatment of schistosomiasis in young children, fexinidazole Winthrop for treatment of an acute form of sleeping sickness, AmBisome® for treating HIV-associated cryptococcal meningitis, and the R21-Matrix MTM malaria vaccine.
232
clinical studies supported by EDCTP2 since 2014 (including phase I-IV studies and diagnostic evaluation studies).
>17
policy documents and guidelines for improved or extended use of existing medical interventions have cited EDCTP-funded research.
Medical interventions
New or improved medical interventions against
poverty-related infectious diseases.
scroll down
Product-focused implementation research, 8 grants
€3.99 M
Non-intervention specific topics, 8 grants
€36.37 M
Diagnostics, 47 grants
€122.83 M
Vaccines, 26 grants
€247.49 M
Drugs, 51 grants
€285.51 M
Note:
A further €110.47M for 246 grants was awarded to projects on non-intervention-specific topics.
*EDCTP grants only
By intervention
Note:
A further €58.01M for 153 grants was awarded to projects on non-disease-specific topics.
*EDCTP grants only
**EDCTP. grants only
Collaborative clinical trials and clinical studies
2003-2018
EDCTP’s investment
in research & development
In 192 projects awarded by end of 2018
€447.04 M
Total funding
€23.15 M
in co-funding has been secured through two dedicated calls requiring collaboration with development cooperation initiatives, with co-funding from Sida, USAID, Gavi, The Global Fund, UNITAID, AECID and Médecins Sans Frontières.
4
calls have been launched targeting development cooperation initiatives and involving 11 projects with development cooperation partners and co-funders.
68
private sector entities are involved in EDCTP projects. By end of 2018 , these organisations have received €49.42 M in grant value.
EU cooperation
Increase interaction with other EU initiatives, including those linked to development assistance.
60%
of the total EDCTP grant value is allocated to sub-Saharan African institutions (€186 million).
€26.84 M
has been leveraged from partners for the launch of joint or coordinated calls for proposals.
16
sub-Saharan African countries are full members of the EDCTP Association. These members have contributed to a total of €1.21 million by end of 2018 through the Participating States’ Initiated Activities (PISIAs) – research activities within the scope of the EDCTP programme that are funded and implemented by one or more member countries.
External partnerships
Increase international cooperation with public
and private partners.
€201.16 M
cash contribution received from the European Participating States to the EDCTP2 programme for the implementation of EDCTP2.
€1.213 Bn
total financial contribution from the European Participating States by the end of 2024. This contribution exceeds the EU target of €683 million related to the matching of funds provided by the European Commission.
European coordination
Improve coordination alignment and integration of
European National Programmes.
29
researchers (14 females and 15 males) funded through the WHO-AFRO/TDR /EDCTP2 Small Grants Scheme for implementation research on infectious diseases of poverty.
23
trainees (15 females and 8 males) funded through ADVAC Advanced Course of Vaccinology.
215
fellowships grants which support 362 fellows (145 females and 217 males).
1,202
trainees from sub-Saharan African countries supported through EDCTP projects (563 females and 639 males).
44
sub-Saharan African countries participate in EDCTP projects involving 309 sub-Saharan African organisations.
30
sub-Saharan African countries were members of the EDCTP Association by the end of 2024.
Collaboration and capacity development
Increase cooperation
with sub-Saharan Africa through capacity building for conducting clinical trials according to ethical principles and regulatory standards
38
Sub-Saharan Africa countries hosts recruitment sites of EDCTP-funded collaborative clinical studies.
5
new/improved medical interventions, including an albendazole–ivermectin combination treatment for parasitic worm infections, arpraziquantel for treatment of schistosomiasis in young children, fexinidazole Winthrop for treatment of an acute form of sleeping sickness, AmBisome® for treating HIV-associated cryptococcal meningitis, and the R21-Matrix MTM malaria vaccine.
232
clinical studies supported by EDCTP2 since 2014 (including phase I-IV studies and diagnostic evaluation studies).
>17
policy documents and guidelines for improved or extended use of existing medical interventions have cited EDCTP-funded research.
Medical interventions
New or improved medical interventions against
poverty-related infectious diseases.
Towards
EDCTP2’s
objectives